Will a new 2017 global leadership commit to NTDs?

Experts of PLOS-NTDs are discussing the impact of the politics of the new United Nations (UN) Secretary General, the Brexit, the election of a new World Health Organization (WHO) Director General, finally the role of the politics of the United States Government, which has so far been the largest financier of NTD mass drug administration (MDA), as well as research and development (R&D) for NTDs. They are asking: How shall we advocate? What does our community of NTD scientists, public health experts, and health care providers want this new global leadership to know about our diseases? What should they prioritize? Submissions, emails, and letters are welcome.

Go back